FIELD: chemistry.
SUBSTANCE: invention relates to novel peptide compounds and their use in diagnostic optical visualisation techniques. More specifically, the present invention pertains to use of such peptide compounds as targeted vectors which are related to receptors associated with angiogenesis. The compounds are labelled using at least one cyanine reporter dye.
EFFECT: obtaining compounds which can be used as contrast agents in optical visualisation when diagnosing diseases related to angiogenesis.
9 cl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PEPTIDE-BASED COMPOUNDS FOR DIRECTED TRANSPORT TO INTEGRIN RECEPTORS | 2002 |
|
RU2303042C2 |
| OPTICAL AGENTS OF VISUALISATION | 2008 |
|
RU2475266C2 |
| MARKED PEPTIDES BINDING HEPATOCYTE GROWTH FACTOR (HGF) FOR VISUALISATION | 2008 |
|
RU2473361C9 |
| CONTRAST AGENT AIMED AT UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR | 2005 |
|
RU2394837C2 |
| VISUALISATION TECHNIQUE | 2008 |
|
RU2505316C2 |
| COMPOSITION FOR OPTICAL VISUALIZATION, METHOD OF ITS PRODUCTION AND USE | 2019 |
|
RU2802481C2 |
| DIAGNOSTIC COMPOUNDS | 2005 |
|
RU2396272C9 |
| VISUALISATION AGENTS | 2004 |
|
RU2355702C2 |
| BISPECIFIC ANTI-HAPTEN/ANTI-BLOOD BRAIN BARRIER RECEPTOR ANTIBODIES, COMPLEXES THEREOF AND THEIR USE AS BLOOD BRAIN BARRIER SHUTTLES | 2014 |
|
RU2693438C2 |
| OPTICAL VISUALISATION AGENTS | 2008 |
|
RU2484111C9 |
